Squarepoint’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,418
| Closed | -$126K | – | 2815 |
|
|
2023
Q4 | $126K | Sell |
29,418
-59,384
| -67% | -$254K | ﹤0.01% | 2234 |
|
|
2023
Q3 | $274K | Buy |
88,802
+69,675
| +364% | +$215K | ﹤0.01% | 1976 |
|
|
2023
Q2 | $86.1K | Buy |
+19,127
| New | +$86.1K | ﹤0.01% | 2233 |
|
|
2022
Q3 | – | Sell |
-19,618
| Closed | -$102K | – | 2419 |
|
|
2022
Q2 | $102K | Sell |
19,618
-11,716
| -37% | -$60.9K | ﹤0.01% | 1868 |
|
|
2022
Q1 | $216K | Sell |
31,334
-17,333
| -36% | -$119K | ﹤0.01% | 1876 |
|
|
2021
Q4 | $606K | Buy |
+48,667
| New | +$606K | ﹤0.01% | 1489 |
|
|
2021
Q1 | – | Sell |
-20,726
| Closed | -$1.48M | – | 2945 |
|
|
2020
Q4 | $1.48M | Sell |
20,726
-33,340
| -62% | -$2.39M | 0.01% | 878 |
|
|
2020
Q3 | $1.63M | Buy |
+54,066
| New | +$1.63M | 0.02% | 716 |
|